WANECAM is the West African Network for Clinical Trials of Antimalarial drugs. This network is being supported by grants from the European & Developing Countries Clinical Trials Partnership (EDCTP).<\/p>\n\n\n\n
The WANECAM 2 project aims to accelerate the development of the Ganaplacide\/lumefantrine combination for the treatment of uncomplicated malaria by conducting clinical trials in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and Niger.<\/p>\n\n\n\n
Read more<\/a><\/p>\n\n\n\n <\/p>\n","protected":false},"excerpt":{"rendered":" WANECAM is the West African Network for Clinical Trials of Antimalarial drugs. This network is being supported by grants from the European & Developing Countries Clinical Trials Partnership (EDCTP). The WANECAM 2 project aims to accelerate the development of the Ganaplacide\/lumefantrine combination for the treatment of uncomplicated malaria by conducting clinical trials in four countries…<\/p>\n","protected":false},"author":1,"featured_media":2282,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[39],"tags":[],"class_list":["post-2376","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-project-en"],"uagb_featured_image_src":{"full":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/WANECAM-1.jpg",360,197,false],"thumbnail":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/WANECAM-1-150x150.jpg",150,150,true],"medium":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/WANECAM-1-300x164.jpg",300,164,true],"medium_large":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/WANECAM-1.jpg",360,197,false],"large":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/WANECAM-1.jpg",360,197,false],"1536x1536":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/WANECAM-1.jpg",360,197,false],"2048x2048":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/WANECAM-1.jpg",360,197,false]},"uagb_author_info":{"display_name":"admin","author_link":"https:\/\/www.mrtc-parasito.org\/PMRTC\/author\/admin\/"},"uagb_comment_info":0,"uagb_excerpt":"WANECAM is the West African Network for Clinical Trials of Antimalarial drugs. This network is being supported by grants from the European & Developing Countries Clinical Trials Partnership (EDCTP). The WANECAM 2 project aims to accelerate the development of the Ganaplacide\/lumefantrine combination for the treatment of uncomplicated malaria by conducting clinical trials in four countries...","rttpg_featured_image_url":{"full":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/WANECAM-1.jpg",360,197,false],"landscape":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/WANECAM-1.jpg",360,197,false],"portraits":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/WANECAM-1.jpg",360,197,false],"thumbnail":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/WANECAM-1-150x150.jpg",150,150,true],"medium":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/WANECAM-1-300x164.jpg",300,164,true],"large":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/WANECAM-1.jpg",360,197,false],"1536x1536":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/WANECAM-1.jpg",360,197,false],"2048x2048":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/WANECAM-1.jpg",360,197,false]},"rttpg_author":{"display_name":"admin","author_link":"https:\/\/www.mrtc-parasito.org\/PMRTC\/author\/admin\/"},"rttpg_comment":0,"rttpg_category":"Project<\/a>","rttpg_excerpt":"WANECAM is the West African Network for Clinical Trials of Antimalarial drugs. This network is being supported by grants from the European & Developing Countries Clinical Trials Partnership (EDCTP). The WANECAM 2 project aims to accelerate the development of the Ganaplacide\/lumefantrine combination for the treatment of uncomplicated malaria by conducting clinical trials in four countries...","_links":{"self":[{"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/posts\/2376","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/comments?post=2376"}],"version-history":[{"count":1,"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/posts\/2376\/revisions"}],"predecessor-version":[{"id":2379,"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/posts\/2376\/revisions\/2379"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/media\/2282"}],"wp:attachment":[{"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/media?parent=2376"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/categories?post=2376"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/tags?post=2376"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}